Trial · NCT01996332
Adverse events374
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 374
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Rhinitis | Infections and infestations | Erlotinib 150 mg/Day | 14 | 1,797 | |
| other | Allergic reaction | Immune system disorders | Erlotinib 150 mg/Day | 3 | 1,797 | |
| other | Vasculitis | Vascular disorders | Erlotinib 150 mg/Day | 3 | 1,797 | |
| other | Hearing | Ear and labyrinth disorders | Erlotinib 150 mg/Day | 5 | 1,797 | |
| other | Tinnitus | Ear and labyrinth disorders | Erlotinib 150 mg/Day | 3 | 1,797 | |
| other | Hemoglobin | Blood and lymphatic system disorders | Erlotinib 150 mg/Day | 89 | 1,797 | |
| other | Platelets | Investigations | Erlotinib 150 mg/Day | 8 | 1,797 | |
| other | Neutrophils | Investigations | Erlotinib 150 mg/Day | 7 | 1,797 | |
| other | Leucocytes | Investigations | Erlotinib 150 mg/Day | 4 | 1,797 | |
| other | Lymphopenia | Investigations | Erlotinib 150 mg/Day | 1 | 1,797 | |
| other | Band neutrophil percentage increased | Investigations | Erlotinib 150 mg/Day | 1 | 1,797 | |
| other | Cardiac arrhythmia | Cardiac disorders | Erlotinib 150 mg/Day | 27 | 1,797 | |
| other | Vasovagal episodes | Nervous system disorders | Erlotinib 150 mg/Day | 3 | 1,797 | |
| other | Palpitations | Cardiac disorders | Erlotinib 150 mg/Day | 1 | 1,797 | |
| other | Pericardial effusion | Cardiac disorders | Erlotinib 150 mg/Day | 8 | 1,797 | |
| other | Cardiac ischemia | Cardiac disorders | Erlotinib 150 mg/Day | 7 | 1,797 | |
| other | Hypotension | Vascular disorders | Erlotinib 150 mg/Day | 7 | 1,797 | |
| other | Cardiopulmonary arrest | Cardiac disorders | Erlotinib 150 mg/Day | 6 | 1,797 | |
| other | Hypertension | Vascular disorders | Erlotinib 150 mg/Day | 5 | 1,797 | |
| other | Left ventricular systolic dysfunction | Cardiac disorders | Erlotinib 150 mg/Day | 5 | 1,797 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01996332/events